Amiodarone hydrochloride

Quick links

Choose a section

Quick links to important sections

Advertisements

Amiodarone hydrochloride

Selected form

Advertisements

Overview of Amiodarone hydrochloride

Property Description
Active Ingredient Amiodarone hydrochloride
Forms Oral tablet, Intravenous solution
Pharmacological Class Antiarrhythmic agent (Class III)
General Purpose Heart rhythm stabilization
Origin Synthetic, Iodinated compound

Amiodarone hydrochloride is a potent, prescription-only medication primarily defined as an antiarrhythmic agent used to stabilize the electrical rhythm of the heart. This synthetic drug belongs to the Class III grouping of antiarrhythmics, a classification based on its distinct action of prolonging the electrical recovery period in the heart muscle. Its use is clinically recognized for managing severe or refractory electrical disturbances.

What Type of Medicine is Amiodarone Hydrochloride?

Amiodarone is formally recognized as a Class III antiarrhythmic agent, which signifies its principal mechanism of blocking potassium ion channels. While primarily considered a Class III agent, it possesses electrophysiological characteristics of all four Vaughan Williams antiarrhythmic classes, giving it a broad-spectrum profile. Chemically, the compound is a synthetic iodinated compound and a benzofuran derivative, a structural feature that differentiates it from non-iodinated antiarrhythmics.

Composition and Available Forms of Amiodarone

The medication is a single-component product whose sole active ingredient is Amiodarone hydrochloride. This active ingredient is supplied in two principal dosage forms: the oral tablet and the sterile intravenous solution (injection). The availability of both forms dictates the oral and intravenous administration routes, providing essential flexibility for treating patients across the spectrum, from acute events to long-term maintenance of heart rhythm.

General Purpose: How Amiodarone Stabilizes the Heart

The general purpose of Amiodarone is to act as a powerful Heart Rhythm Stabilizer, correcting and preventing dangerous abnormalities in the heart’s electrical system. This medication is typically used when patients experience recurrent, life-threatening ventricular electrical disturbances that are unresponsive to less potent alternatives. By significantly lengthening the time the heart cells need to recover after each electrical impulse (the refractory period), the drug dampens erratic electrical activity. This physiological action is essential for maintaining the heart's electrical integrity, allowing it to beat with a more regular and steady pace.

Advertisements

What side effects are possible with Amiodarone hydrochloride?

Possible Side Effects and Safety Information

The safety profile of Amiodarone hydrochloride is officially documented through structured regulatory classifications, reflecting potential adverse reactions across several critical organ systems. Due to the drug's long half-life, the regulatory labeling notes that adverse effects can persist for several weeks following discontinuation of therapy.

Official Adverse Reaction Classifications

Adverse reactions are formally grouped by frequency and the organ system affected, based on official government sources. Major systemic concerns include effects on the pulmonary, hepatic (liver), thyroid, and ocular (eye) systems.

Frequency Classification Examples of Documented Adverse Reactions
Very Common (ge 1/10) Corneal microdeposits, moderate increase in serum transaminases, GI symptoms (nausea, vomiting).
Common (ge 1/100 to < 1/10) Hypothyroidism, hyperthyroidism, bradycardia, skin photosensitivity.
Uncommon Worsening of arrhythmia (proarrhythmia), peripheral neuropathy, conduction disturbances.
Very Rare Marked bradycardia/sinus arrest, chronic liver disease, optic neuropathy/neuritis.

Serious Adverse Reactions and Safety Patterns

Regulatory documents explicitly list severe pulmonary toxicity (e.g., interstitial fibrosis), worsened arrhythmia, and severe hepatic injury as serious, potentially fatal adverse reactions. Specific safety patterns are also noted:

  • Time-Related: Gastrointestinal symptoms are usually associated with the loading dosage. Hypotension during intravenous use is most often seen in the first several hours and is related to the infusion rate. Blue-gray skin discoloration is associated with long-term exposure.
  • Population-Specific: The safety and efficacy of the drug have not been established in pediatric patients. Older adults have an increased potential for officially documented marked bradycardia or sinus arrest.
Advertisements

Overdose and Emergency Response

Amiodarone hydrochloride overdose is a serious medical emergency that requires immediate professional attention. Due to its long half-life, the effects of an overdose may be delayed or prolonged. Management of an overdose is generally supportive, as Amiodarone and its main metabolite are not easily removed from the body by dialysis.

Recognizing an Overdose

Symptoms of Amiodarone overdose can primarily involve the heart and circulatory system, but may also affect the nervous system. Key signs include:

  • Cardiovascular: Extremely slow heartbeat (severe bradycardia), dangerously low blood pressure (hypotension), and new or worsened heart rhythm disturbances.
  • Neurological/Systemic: Severe lightheadedness, fainting or loss of consciousness, blurred vision, and pronounced weakness.

When to Seek Help

Call for emergency medical services (e.g., 911 or your local emergency number) immediately if you or someone else has taken more than the prescribed dose of Amiodarone hydrochloride, even if symptoms are not yet apparent. This is a life-threatening event, and immediate transport to an emergency room is critical for proper monitoring and supportive care, which may include temporary cardiac pacing or the use of medications to support blood pressure.

Do not wait for symptoms to worsen before seeking help. Always contact a poison control center for guidance if an overdose is suspected.

Advertisements

Therapeutic Uses of Amiodarone hydrochloride

Main Uses of Amiodarone Hydrochloride

Amiodarone hydrochloride is a specialized medication primarily used to manage certain types of serious, life-threatening heart rhythm disorders, known as arrhythmias. It is classified as a Class III antiarrhythmic agent. Its primary function is to stabilize the electrical activity in the heart to restore and maintain a normal, steady heartbeat.

Ventricular Arrhythmias

This medication is specifically indicated for the treatment of severe ventricular arrhythmias. These occur in the lower chambers of the heart (the ventricles) and can be life-threatening if left unmanaged. Key conditions include:

  • Recurrent Ventricular Fibrillation (VF): A condition where the heart quivers instead of pumping due to disorganized electrical activity.
  • Recurrent Hemodynamically Unstable Ventricular Tachycardia (VT): A fast heart rate that originates in the ventricles and is severe enough to prevent the heart from pumping enough blood to the body.

Because of its potency, amiodarone hydrochloride is typically reserved for patients who have not responded to other available antiarrhythmic treatments or who cannot tolerate other medications.

Off-Label and Secondary Uses

While its primary indication is for ventricular issues, clinicians sometimes utilize amiodarone hydrochloride for other rhythm disturbances when other options are ineffective. This may include certain types of supraventricular arrhythmias, such as atrial fibrillation, particularly in patients with specific underlying heart conditions.

Benefits of Treatment

The primary benefit of amiodarone hydrochloride is its efficacy in rhythm control. Unlike some other medications that only control the heart rate, amiodarone works to correct the rhythm itself.

  • Restoration of Normal Rhythm: By affecting the electrical signals in heart tissue, it helps the heart return to a consistent sinus rhythm.
  • Reduction in Arrhythmia Frequency: For patients with chronic heart rhythm instability, it can significantly decrease the frequency of sudden, dangerous cardiac episodes.
  • Support for Complex Heart Profiles: It is often a viable option for patients with structural heart disease or reduced heart function who may not be candidates for other types of antiarrhythmic drugs.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Amiodarone Hydrochloride

Official regulatory information defines specific populations that are permitted, restricted, or prohibited from using Amiodarone hydrochloride.

Populations Prohibited from Use (Contraindications)

Use is contraindicated in patients with certain severe pre-existing conditions, including cardiogenic shock and severe cardiac conduction disorders such as second- or third-degree atrioventricular (AV) block or sick sinus syndrome, unless a functional pacemaker is present. The drug is also prohibited for individuals with known hypersensitivity to amiodarone, its components, or to iodine.

Age and Physiological Restrictions

Population Group Regulatory Status
Pediatric Patients (under 18) Safety and effectiveness have not been established.
Pregnant Patients Classified as Pregnancy Category D; generally restricted unless benefits outweigh fetal risk.
Breastfeeding Patients Not recommended due to drug excretion into breast milk.
Older Adults Use is documented as acceptable but may require closer monitoring.

Conditional Use Requirements

Treatment is conditional upon correcting electrolyte abnormalities; specifically, pre-existing hypokalemia or hypomagnesemia must be corrected prior to administration. Patients with pre-existing thyroid abnormalities or severe hepatic injury require strict monitoring and may necessitate discontinuation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Documented Pharmacokinetic Interactions

Amiodarone is officially documented as a potent inhibitor of multiple metabolic enzymes, notably CYP2C9, CYP2D6, and CYP3A, and the transporter P-glycoprotein (P-gp). This inhibition increases the systemic exposure of many co-administered substances, including the oral anticoagulant Warfarin, the cardiac glycoside Digoxin, and certain Statins (e.g., Simvastatin). Official regulatory documents specify mandatory administration restrictions for this interaction: co-administration with Simvastatin must not exceed 20 mg/day, and doses of Warfarin and Digoxin typically require a reduction of 25 to 50% upon initiation of Amiodarone therapy.

Pharmacodynamic and Contraindicated Interactions

The medicine's effect on heart rhythm creates documented pharmacodynamic interactions. Co-administration with Beta Blockers or certain Calcium Channel Blockers (e.g., Diltiazem) may potentiate bradycardia and conduction slowing. Contraindicated combinations include other medicinal products known to prolong the QT interval and increase the risk of Torsades de Pointes. Additionally, an interaction with Food is officially noted, as a high-fat meal significantly increases the overall absorption of Amiodarone into the system.

Advertisements

Mechanism of Action

Amiodarone hydrochloride exhibits a multichannel block mechanism of action, primarily functioning as a Class III antiarrhythmic agent. Its core activity involves the non-competitive inhibition of potassium rectifier currents, specifically those channels responsible for the repolarization phase (Phase 3) of the cardiac action potential. This inhibitory action directly prolongs the action potential duration (APD) and extends the effective refractory period (ERP) within myocardial cells.

Additionally, amiodarone displays antagonistic activity across multiple other cardiac ion channels. It blocks sodium channels (Class I), which serves to slow the conduction velocity of electrical impulses by reducing the maximal rate of action potential upstroke. The compound also modulates calcium channels (Class IV). Furthermore, amiodarone and its active metabolite, desethylamiodarone, are non-competitive inhibitors of alpha- and beta-adrenergic receptors (Class II). The composite pharmacological profile results in reduced automaticity of the sinoatrial node and decreased conduction velocity through the atrioventricular node. The drug also interferes with peripheral thyroid hormone metabolism, inhibiting the conversion of thyroxine (T4) to triiodothyronine (T3).

Advertisements

Dosage and Administration Information

How to Use Amiodarone Hydrochloride: Administration Guidelines

Amiodarone hydrochloride is available for use by oral (tablet) and intravenous (IV) routes. Treatment is typically initiated and monitored under specialist supervision due to the serious nature of the conditions it treats and the complexity of its dosing.

Oral Administration (Tablets)

Oral dosing is divided into distinct phases to achieve and maintain therapeutic levels. The initial loading phase typically ranges from 800 mg to 1600 mg per day, divided into two or three doses, and continues for one to three weeks. This is followed by a transitional reduction phase and a long-term maintenance dose, often 400 mg daily or the minimum effective dose. Oral tablets should be administered with meals to help reduce gastrointestinal irritation. Consumption of grapefruit juice should be avoided during treatment.

Intravenous Administration (Injection/Infusion)

IV administration is used when rapid control of life-threatening arrhythmias is required. The typical 24-hour regimen involves three parts: a rapid loading infusion (150 mg over 10 minutes), a slow loading infusion (360 mg over the next 6 hours), and a continuous maintenance infusion (540 mg over the remaining 18 hours, at 0.5 mg/min). IV solutions must be diluted with D5W (5% Dextrose in Water) and should be administered through an in-line filter. For concentrations greater than 2 mg/mL, administration via a central venous catheter is required.

Age-Specific Rules and Preparations

There is no established safety and efficacy data for use in children, and no recommended pediatric posology (dosing). Elderly patients should be started on the minimum effective dose. Prior to administration, any existing electrolyte imbalances such as hypokalemia (low potassium) must be corrected.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Amiodarone Hydrochloride

Evidence for Use in Life-Threatening Ventricular Arrhythmias

Research exploring Amiodarone hydrochloride has focused on its role in addressing severe, life-threatening electrical disturbances in the lower heart chambers (VF and unstable VT). Studies was evaluated in both intravenous and oral forms, often through Randomized Controlled Trials (RCTs) and meta-analyses, monitoring the recurrence rate of ventricular events and patterns related to cardiac mortality. Findings describe patterns related to the reduction of recurrent ventricular events in patients who had not responded to other medications. What remains uncertain is the full scope of long-term total survival. While research describes patterns related to reduced risk of arrhythmic death, the overall impact on all-cause mortality is an area where findings were inconsistent across different study designs.

Evidence for Use in Atrial Fibrillation and Atrial Flutter

Amiodarone hydrochloride was studied for managing electrical issues in the upper heart chambers (AF and AFL). Studies was evaluated in two key areas: restoring a normal heart rhythm (cardioversion) and maintaining that stable rhythm. Studies report how patient-reported outcomes describing perceived discomfort evolved, and monitored the proportion of patients able to maintain a stable rhythm. Certainty remains low regarding whether rhythm control with this medication offers a pattern of outcomes for overall total survival when compared to rate control strategies in all AF populations. The long-term maintenance of the observed patterns is a topic where certainty remains low.

Evidence in High-Risk Cardiac Populations

Large-scale clinical trials were evaluated in adults considered high-risk due to a recent myocardial infarction (MI) or severe congestive heart failure (CHF). Research that examined outcomes such as sudden cardiac death (SCD) and all-cause mortality describes how patterns related to reduced sudden cardiac death were observed in some groups. However, the data show patterns related to mixed results for total mortality, and findings for a reduction in total mortality were inconsistent across all studied populations.

Key Studies & References

  1. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
  2. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amiodarone hydrochloride (FAQ)

Q: Is Amiodarone hydrochloride considered a blood thinner?

A: Regulatory documents classify Amiodarone hydrochloride as an antiarrhythmic agent, which is used to stabilize the heart’s electrical rhythm. It is not classified as an anticoagulant or a 'blood thinner.' However, official labeling notes that it does have important documented interactions with anticoagulant medicines.

Q: How long does it typically take for Amiodarone hydrochloride to start working for a rhythm problem?

A: Amiodarone is typically started with a loading phase to reach effective levels, which regulatory documents describe as taking one to three weeks. Due to the medicine's long half-life (meaning it stays in the body for a long time), the medicine's therapeutic levels, which lead to heart rhythm stabilization, may take this length of time to become established.

Q: What are the signs of liver problems related to Amiodarone hydrochloride?

A: Serious liver injury is a documented adverse reaction in official product information. Official information describes signs that may indicate a liver problem, such as a yellowing of the skin or eyes (jaundice), unusual tiredness, nausea, vomiting, or dark urine.

Q: Does Amiodarone hydrochloride make you tired or cause fatigue?

A: While the term 'fatigue' may not be explicitly listed, regulatory documents describe that feeling tired or weak, known as asthenia, is a documented adverse reaction.

Q: Is it normal to feel dizzy when first starting Amiodarone hydrochloride?

A: Official side effects data show that dizziness, lightheadedness, and feeling faint have been reported by patients taking this medicine. These effects are typically reported in official side effects data.

Q: How often do people need blood tests while on Amiodarone hydrochloride?

A: Regulatory authorities state that liver function and thyroid function tests should be performed before starting treatment. Monitoring is typically required at regular intervals throughout therapy, as determined by the prescribing physician based on official guidelines.

Q: Are there specific vitamins or supplements that interact with Amiodarone hydrochloride?

A: Official documents do not list many common vitamins as direct interactions. However, regulatory requirements stress that mineral imbalances, particularly low potassium (hypokalemia) or low magnesium (hypomagnesemia), must be corrected prior to beginning administration.

Q: Does Amiodarone hydrochloride affect a person's weight?

A: Weight changes are documented as potential effects of Amiodarone hydrochloride. This may be associated with the medicine's documented effects on thyroid hormone metabolism, which is a key area of monitoring during treatment.

Q: What are the main risks associated with stopping Amiodarone hydrochloride suddenly?

A: Official documents warn that stopping this medication may be associated with the recurrence of the original life-threatening heart rhythm disorder or a worsening of the existing condition. Regulatory warnings emphasize the need for medical supervision when discontinuing treatment.

Q: Does Amiodarone hydrochloride interact with common cold or allergy medicines?

A: Regulatory information warns about the risk of interaction with any medicine that also affects heart rate or rhythm. This includes over-the-counter products that may contain ingredients that prolong the QT interval or affect the adrenergic system.

Q: Why is Amiodarone hydrochloride sometimes used in people with implanted defibrillators?

A: Amiodarone hydrochloride is approved for the treatment of life-threatening ventricular arrhythmias. Regulatory review confirms its use in patients to reduce the recurrence of these events, which can trigger an implanted cardioverter defibrillator (ICD) to fire.

Q: Can Amiodarone hydrochloride change my sense of taste or smell?

A: Official documents describe that disturbances in taste (dysgeusia) and smell are documented adverse reactions.

Q: How often does the skin discoloration side effect occur with Amiodarone hydrochloride?

A: Blue-gray skin discoloration is officially noted as being associated with long-term exposure. This reaction is officially classified as uncommon.

Q: Can Amiodarone hydrochloride cause tremors or shaking?

A: Tremor, which is an involuntary shaking, is described in regulatory documents as an uncommon adverse reaction. This reaction is officially classified as uncommon.

Q: Does Amiodarone hydrochloride interact with herbal supplements like St. John's wort?

A: Regulatory documents specifically list the herbal supplement St. John's wort as an interacting substance. This interaction may reduce the effectiveness of Amiodarone hydrochloride in the body.

Q: Can I take Amiodarone hydrochloride if I forget a dose?

A: According to the official guidance provided by the National Institutes of Health, if a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. If it is nearly time for the next dose, the missed dose should be skipped. The guidance specifies that the dose should not be doubled.

Q: Is it typical to experience trouble sleeping while on Amiodarone hydrochloride?

A: Trouble sleeping, or insomnia, is described in regulatory documents as an uncommon adverse reaction. This reaction is officially classified as uncommon.

Q: Are there food restrictions other than grapefruit when taking Amiodarone hydrochloride?

A: In addition to the need to avoid grapefruit juice, official documents note that Amiodarone hydrochloride should be taken with meals. This is because a high-fat meal can increase the amount of medicine absorbed by the body. No other food is officially listed as a restriction.

Q: What kind of specialist typically manages treatment with Amiodarone hydrochloride?

A: Official documents state that treatment must be initiated and monitored under the supervision of a specialist. Official documents require supervision by a specialist experienced in treating severe heart rhythm issues.

Advertisements

How should Amiodarone hydrochloride be stored and disposed of?

Storage and Disposal Requirements

Amiodarone hydrochloride must be stored according to official regulatory specifications to maintain its effectiveness. Tablets require storage at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), and must be kept out of the reach and sight of children.

Handling the Injection

The intravenous solution must be protected from light and kept in its original outer carton. When preparing the injection, only 5% Dextrose in Water ( D5 W) is compatible as a diluent; normal saline must not be used. For prolonged infusions, administration requires glass or polyolefin containers and DEHP-free sets, as outlined in the official labeling.

Disposal

All unused or expired Amiodarone product must be disposed of in accordance with local regulations for pharmaceutical waste. Household disposal of tablets, where permitted, involves mixing the medication with an undesirable substance before discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amiodarone hydrochloride found in:

A-Z Index: